Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

MiADMSA is a heavy metal chelator and an ester form of meso-2,3-dimercaptosuccinic acid (Item No. 28515).1,2 MiADMSA (100 nM) inhibits arsenic-induced increases in reactive oxygen species (ROS), colony formation, and migration and prevents arsenic-induced decreases in glutathione (GSH) levels in NBT-II rat bladder cancer cells.2 It reduces apoptosis and increases mitochondrial electron transport chain activity in rat neurons in a model of arsenic exposure.1 Oral administration of MiADMSA (50 mg/kg) decreases brain arsenic levels and increases urinary levels in arsenic-exposed rats.
WARNING This product is not for human or veterinary use.
1. MiADMSA reverses impaired mitochondrial energy metabolism and neuronal apoptotic cell death after arsenic exposure in rats. Toxicol. Appl. Pharmacol. 256(3), 241-248 (2011).
2. MiADMSA ameliorate arsenic induced urinary bladder carcinogenesis in vivo and in vitro. Biomed. Pharmacother. 128:110257, (2020).